16-85918487-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_002163.4(IRF8):​c.672C>T​(p.Pro224Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00334 in 1,591,368 control chromosomes in the GnomAD database, including 132 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. P224P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.017 ( 61 hom., cov: 33)
Exomes 𝑓: 0.0019 ( 71 hom. )

Consequence

IRF8
NM_002163.4 synonymous

Scores

1
6

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -2.97

Publications

2 publications found
Variant links:
Genes affected
IRF8 (HGNC:5358): (interferon regulatory factor 8) Interferon consensus sequence-binding protein (ICSBP) is a transcription factor of the interferon (IFN) regulatory factor (IRF) family. Proteins of this family are composed of a conserved DNA-binding domain in the N-terminal region and a divergent C-terminal region that serves as the regulatory domain. The IRF family proteins bind to the IFN-stimulated response element (ISRE) and regulate expression of genes stimulated by type I IFNs, namely IFN-alpha and IFN-beta. IRF family proteins also control expression of IFN-alpha and IFN-beta-regulated genes that are induced by viral infection. [provided by RefSeq, Jul 2008]
MIR6774 (HGNC:50202): (microRNA 6774) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0068588853).
BP6
Variant 16-85918487-C-T is Benign according to our data. Variant chr16-85918487-C-T is described in ClinVar as Benign. ClinVar VariationId is 475392.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.97 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0577 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IRF8NM_002163.4 linkc.672C>T p.Pro224Pro synonymous_variant Exon 7 of 9 ENST00000268638.10 NP_002154.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IRF8ENST00000268638.10 linkc.672C>T p.Pro224Pro synonymous_variant Exon 7 of 9 1 NM_002163.4 ENSP00000268638.4

Frequencies

GnomAD3 genomes
AF:
0.0172
AC:
2618
AN:
152224
Hom.:
62
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0597
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00582
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000353
Gnomad OTH
AF:
0.0124
GnomAD2 exomes
AF:
0.00456
AC:
1050
AN:
230362
AF XY:
0.00333
show subpopulations
Gnomad AFR exome
AF:
0.0638
Gnomad AMR exome
AF:
0.00232
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000227
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000159
Gnomad OTH exome
AF:
0.000857
GnomAD4 exome
AF:
0.00188
AC:
2699
AN:
1439026
Hom.:
71
Cov.:
31
AF XY:
0.00162
AC XY:
1158
AN XY:
714980
show subpopulations
African (AFR)
AF:
0.0659
AC:
2191
AN:
33226
American (AMR)
AF:
0.00293
AC:
130
AN:
44380
Ashkenazi Jewish (ASJ)
AF:
0.0000779
AC:
2
AN:
25664
East Asian (EAS)
AF:
0.0000759
AC:
3
AN:
39506
South Asian (SAS)
AF:
0.000141
AC:
12
AN:
85052
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40426
Middle Eastern (MID)
AF:
0.00346
AC:
15
AN:
4338
European-Non Finnish (NFE)
AF:
0.0000886
AC:
98
AN:
1106718
Other (OTH)
AF:
0.00415
AC:
248
AN:
59716
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
168
335
503
670
838
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
70
140
210
280
350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0172
AC:
2621
AN:
152342
Hom.:
61
Cov.:
33
AF XY:
0.0167
AC XY:
1245
AN XY:
74500
show subpopulations
African (AFR)
AF:
0.0596
AC:
2479
AN:
41564
American (AMR)
AF:
0.00582
AC:
89
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000353
AC:
24
AN:
68042
Other (OTH)
AF:
0.0123
AC:
26
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
127
254
382
509
636
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00207
Hom.:
0
Bravo
AF:
0.0197
ESP6500AA
AF:
0.0567
AC:
247
ESP6500EA
AF:
0.000471
AC:
4
ExAC
AF:
0.00537
AC:
647
Asia WGS
AF:
0.00549
AC:
20
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency;C4751209:Immunodeficiency 32B Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
7.4
DANN
Benign
0.74
FATHMM_MKL
Benign
0.17
N
MetaRNN
Benign
0.0069
T
PhyloP100
-3.0
PROVEAN
Pathogenic
-10
D
MVP
0.72
GERP RS
-0.95
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs57770209; hg19: chr16-85952093; API